CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $392,000 | -11.1% | 21,311 | -11.3% | 0.00% | – |
| Q3 2020 | $441,000 | +312.1% | 24,026 | +235.2% | 0.00% | – |
| Q2 2020 | $107,000 | -21.9% | 7,167 | -17.2% | 0.00% | – |
| Q1 2020 | $137,000 | -44.5% | 8,660 | -43.0% | 0.00% | – |
| Q4 2019 | $247,000 | +63.6% | 15,186 | +49.4% | 0.00% | – |
| Q3 2019 | $151,000 | +139.7% | 10,162 | +168.0% | 0.00% | – |
| Q2 2019 | $63,000 | +472.7% | 3,792 | +500.0% | 0.00% | – |
| Q1 2019 | $11,000 | -85.5% | 632 | -85.3% | 0.00% | – |
| Q4 2018 | $76,000 | +43.4% | 4,286 | +46.5% | 0.00% | – |
| Q3 2018 | $53,000 | +32.5% | 2,925 | +43.0% | 0.00% | – |
| Q2 2018 | $40,000 | +150.0% | 2,046 | +35.8% | 0.00% | – |
| Q3 2017 | $16,000 | +1500.0% | 1,507 | +1050.4% | 0.00% | – |
| Q2 2017 | $1,000 | -93.8% | 131 | -90.2% | 0.00% | – |
| Q1 2017 | $16,000 | -65.2% | 1,339 | -61.6% | 0.00% | – |
| Q4 2016 | $46,000 | -4.2% | 3,484 | +4.2% | 0.00% | – |
| Q3 2016 | $48,000 | +92.0% | 3,344 | +122.6% | 0.00% | – |
| Q3 2015 | $25,000 | -84.2% | 1,502 | -64.3% | 0.00% | – |
| Q2 2015 | $158,000 | -69.9% | 4,203 | -74.8% | 0.00% | – |
| Q1 2015 | $525,000 | +1444.1% | 16,700 | +527.1% | 0.00% | – |
| Q4 2014 | $34,000 | – | 2,663 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|